...
首页> 外文期刊>癌と化学療法 >A case of partial response in liver metastatic lesion from gastric endocrine cell carcinoma treated with TS-1
【24h】

A case of partial response in liver metastatic lesion from gastric endocrine cell carcinoma treated with TS-1

机译:用TS-1处理胃内分泌细胞癌肝转移性病变的部分反应的情况

获取原文
获取原文并翻译 | 示例

摘要

Endocrine cell carcinoma (ECC) of the stomach is a rare pathological type with a poor outcome. Standard chemotherapy has not yet been established. We experienced a case of partial response in the liver metastasis from the gastric ECC treated with TS-1. The patient was a 68-year-old female. An upper GI series and gastroendoscopy revealed pyrolus stenosis and CT-scan showed liver metastasis. A non-curative total gastrectomy was performed to allow oral intake. Since the histopathological examination revealed that tumor cells were partially positive for chromogranin A on immunohistochemical study, we diagnosed tumor ECC of the stomach. The patient with liver metastasis was treated using TS-1, and CT-scan showed a remarkable decrease (PR) in the metastatic lesion. TS-1 administration can improve the clinical outcome for ECC of the stomach.
机译:胃的内分泌细胞癌(ECC)是一种罕见的病理类型,结果差。 尚未建立标准化疗。 我们在用TS-1处理的胃ECC中经历了肝转移中部分反应的情况。 患者是68岁的女性。 上GI系列和胃肠镜检查显示皮酚狭窄和CT扫描显示肝转移。 进行非疗效总胃切除术以允许口服摄入量。 由于组织病理学检查表明,肿瘤细胞在免疫组织化学研究上部分阳性的染色体蛋白A,我们诊断出胃的肿瘤ECC。 使用TS-1处理具有肝转移的患者,并且CT-Scan在转移性病变中显示出显着的降低(PR)。 TS-1给药可以改善ECC的胃肠的临床结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号